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between PGCLC and EB/ESC/EpiLC/EpiSC 
(n=100)
Supplementary Fig.1: Characterization of the PGCLC differentiation system by scRNA-seq 
(related to Fig. 1). 
a.) The average gene expression for the specific markers defining the main embryonic and 
extraembryonic tissues found within E8.25 mouse embryos1 is shown for the cell clusters 
identified within d4 EBs. Since PGC markers were not identified by Ibarra-Soria et al. 20181, we 
used the core PGC gene set previously defined by Nakaki et al. 20162 as a representative set of 
PGC markers expressed in E9.5 embryos. The numbers next to each tissue name indicate the 
sample size considered for each tissue (tissue markers with logFC >2.5). The horizontal lines in 
the boxplots indicate the median, the boxes the first and third quartiles and the whiskers the  ± 1.5 
× interquartile range.  
b.) Heatmap showing the expression of representative markers for the main four cell clusters 
identified within d4 EBs (Fig. 1C; Endothelial, PGCLC, ExE-LC and ExM-LC). The expression 
values are displayed as UMI (unique molecular identifier) counts in log2 scale.  
c.) Expression dynamics of the PGCLC genes during PGCLC formation. Each dot represents the 
mean expression of a PGCLC gene in all cells belonging to the indicated stages. EB refers to any 
cell of the EB except those identified as PGCLC (n = 389). The horizontal lines in the boxplots 
indicate the median, the boxes the first and third quartiles and the whiskers the   ±  1.5  × 
interquartile range. 
d.) Violin plots showing the expression of selected ESC markers (Klf4, Zfp57), genes active in 
both ESC and PGCLC (shared: Esrrb, Tfap2c), and PGCLC markers (Dppa3, Prdm1) in 2i ESC, 
d2 EpiLC, EpiSC, d2 EB, d4 EB and the PGCLC cluster. EB refers to all cells of the EBs, except 
those found within the PGCLC cluster. 
e.) PGCLC genes specifically expressed in PGCLC were identified by performing a differential 
expression analysis of PGCLC vs EB/ESC/EpiLC/EpiSC. The expression dynamics of the 
resulting PGCLC-specific genes (n=100) is shown, with each dot representing the mean 
expression of the PGCLC-specific genes in a single cell belonging to the indicated stages. EB 
refers to all cells of the EB except those found within the  PGCLC cluster. The horizontal lines in 
the boxplots indicate the median, the boxes the first and third quartiles and the whiskers the  ± 1.5 
× interquartile range.  
f.) RNA velocity was used as a computational approach to investigate potential transcriptional 
priming of the PGCLC expression program in d2 EpiLC. The RNA velocity analysis, which takes 
into account unspliced transcript reads for lineage tracing, did not show any evidence of 
transcriptional priming of d2 EpiLC (red) towards the PGCLC cluster (gray). In contrast, this same 
analysis revealed that a fraction of the cells profiled for the d2 EB (with a mixed mesodermal/
PGCLC identity; gray arrow) seem to acquire a transcriptional program similar to the one found 
for PGCLC (shadowed in gray), indicating the feasibility of the RNA velocity method to detect 
transcriptional priming. 
g.) Scatter plots comparing the transcriptomes of WT d2 EpiLC (x-axis) with those of d1.5 EpiLC, 
d3 EpiLC, Prdm14-/- d2 EpiLC or Otx2-/- d2 EpiLC (y-axis). All genes considered as expressed are 
shown as dots, with the PGCLC genes highlighted in green. The gene expression values are r-log 
normalized. The RNA-seq data was obtained from Yang et al. 20193, Buecker et al. 20144 and 
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Gating strategy of PGCLC
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Supplementary Fig. 2: Deletion and functional evaluation of representative PGCLC 
enhancers (related to Fig. 2). 
a.) Heatmaps showing H3K27ac ChIP-seq signals during PGCLC differentiation around all the 
distal H3K27ac peaks called in d6 PGCLC. The H3K27ac peaks were called using two H3K27ac 
ChIP-seq replicates generated in d6 PGCLC and only those peaks located >2 Kb from gene TSS 
were considered (see Methods). The H3K27ac ChIP-seq data from d2 and d6 PGCLC was 
obtained from Kurimoto et al. 20156. RPGC: reads per genomic content. 
b.) Genome-browser view of the H3K27ac and CpG methylation dynamics during PGCLC 
differentiation for the PGCLC enhancers, highlighted in blue, found within within the Klf5 (top) and 
Lrrc31/Lrrc34 (bottom) loci. The blue rectangles denote the enhancer deletions generated in 
mESC using CRISPR/Cas9 technology. According to capture Hi-C data generated in ESC7, the 
Klf5 enhancer is physically linked to the Klf5 TSS, while the Lrrc31/Lrrc34 enhancer is directly 
linked to the Lrrc34 TSS, which itself interacts with Lrrc31 (orange line). The H3K27ac PGCLC 
data was obtained from Kurimoto et al. 20156 and the CpG methylation data from Shirane et al. 
20165.  RPGC: reads per genomic content. 
c.) The different PGCLC enhancer deletions generated in ESC were confirmed by PCR 
genotyping followed by Sanger sequencing. This is illustrated by chromatograms showing the 
deletions generated for the Esrrb, Prdm14 E1 and Lrrc31/34 PGCLC enhancers. The reference 
sequence for each enhancer together with the corresponding CRISPR/Cas9 gRNAs (highlighted 
in orange) are shown above the chromatograms. 
d-e.) Klf5 (d), Lrrc31 and Lrrc34 (e) expression were measured by RT-qPCR in d4 EB 
differentiated from WT ESC and two different ESC clonal lines with the Lrrc31/Lrrc34 (d) or Klf5 
(e) enhancer deletions. The expression values were normalized to two housekeeping genes 
(Eef1a1 and Hprt). The bar plots show the mean expression +/- SD from 6 measurements shown 
as circles (two clonal lines x three technical replicates). 
f.) FACS gating strategy and representative examples of the PGCLC quantifications performed by 
FACS after four days of PGCLC differentiation using WT ESC (E14 WT) or ESC with deletions of 
each of the three Prdm14 enhancers (∆E1-E3). As a negative control, the WT ESC were also 
differentiated in the absence of BMP4 (-BMP4 ctrl). PGCLC were defined as the CD15+CD61+ 
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ChIP−qPCR − H3K4me1
Supplementary Fig. 3: Epigenomic profiling of PGCLC enhancers (related to Fig. 3). 
a.) Summary plot showing the average levels of H3K4me3, H3K9me2 and H3K27me2 measured 
in 2i ESC, d2 EpiLC and EpiSC for the EpiLC, EpiSC and PGCLC enhancers as well as the 
transcription start site (TSS) of the PGCLC genes. Quantifications were performed by measuring 
the average signals of each epigenetic mark within -/+ 1kb of the enhancers or TSS. RPGC: 
Reads per genomic content. 
b.) Average profile (top) and heatmap (bottom) plots showing H3K4me1 levels for the Group I and 
Group II PGCLC enhancers in 2i ESC, d2 EpiLC and EpiSC. For the comparison between EpiLC 
and EpiSC, a paired Wilcoxon test was performed and the p-values for Group I and II PGCLC 
enhancers are indicated. The H3K4me1 signals correspond to the second (E14 cells) and third 
(R1 cells) ChIP-seq replicates generated in each cell type. Scales are shown in RPGC. 
c.) H3K4me1 ChIP-qPCR analyses for the PGCLC enhancers of Esrrb, Klf5 and Lrrc31/34 in d2 
EpiLC and EpiSC differentiated from E14 ESC. The H3K4me1 enrichments levels were 
normalized to a negative control region and are shown in log2 scale. The bar plots show the 
mean +/- SD from three technical replicates (circles). 
d.) Average profile (top) and heatmap (bottom) plots showing H3K9me2, H3K4me2, H3K27ac and 
ATAC-seq (from two biological replicates), H3K27me2 and H3K27me3 levels for the Group I and 
Group II PGCLC enhancers in 2i ESC, d2 EpiLC and EpiSC. For the comparison between EpiLC 
and EpiSC, a paired Wilcoxon test was performed and the p-values for Group I and II PGCLC 
enhancers are indicated. Scales are shown in RPGC. 
e.) Genome-browser view showing representative PGCLC enhancers interacting with Sox2 
according to capture Hi-C generated in ESC (Atlasi et al. 20197, blue arc) as well as the levels of 
several epigenetic marks in 2i ESC, d2 EpiLC and EpiSC. The H3K27ac PGCLC data was 
obtained from Kurimoto et al. 20156 and the CpG methylation data from Shirane et al. 20165 and 
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Supplementary Fig. 4: Characterization of PGCLC enhancers in Otx2-/- cells and upon 
overexpression of major germline regulators (related to Fig. 4). 
a.) Representative examples of the PGCLC quantifications performed by FACS after four days of 
PGCLC differentiation starting from d2 EpiLC, d4 EpiSC and d8 EpiSC for either E14 WT (top) or 
E14 Otx2-/- (bottom) cells. PGCLC were quantified as the CD15+CD61+ cells found within d4 EB. 
b.) Average profile (top) and heatmap (bottom) plots showing H3K27ac signals for the Group I and 
Group II PGCLC enhancers in E14 WT and Otx2-/- d2 EpiLC. For the comparison between  WT and 
Otx2-/- EpiLC, a paired Wilcoxon test was performed and the p-values for Group I and II PGCLC 
enhancers are indicated. Scales are shown in RPGC. 
c.) H3K4me1 (top) and H3K4me2 (middle) ChIP-qPCR analyses for selected PGCLC enhancers in 
E14 WT and Otx2-/- cells (2i ESC and d2 EpiLC). H3K4me1 and H3K4me2 enrichment levels were 
normalized to a negative control region and shown in log2 scale. The bar plots show the mean +/- 
SD from three technical replicates. The bottom panel shows the expression values for the genes 
associated with the selected PGCLC enhancers using RNA-seq data from Buecker et al. 20144. 
d.) CpG methylation levels of selected PGCLC enhancers linked to Esrrb and Prdm1 genes were 
measured by bisulfite sequencing in d2 EpiLC, d4 EpiSC and d8 EpiSC differentiated from E14 WT 
and Otx2-/- ESC. The columns of the plots correspond to individual CpG dinucleotides located within 
the indicated enhancer. Unmethylated CpGs are shown in blue, methylated CpGs in red and CpGs 
that were not sequenced are shown in gray. The rows represent the sequenced alleles in each cell 
line.  
e-f.) Western blot analysis of the inducible overexpression of exogenous PRDM14-HA (e) and 
NANOG-HA (f). EpiLC or EpiSC were either left untreated (ctrl) or treated with Dox for 18 hours. (e) 
PRDM14-HA levels were measured using an anti-HA antibody and the band corresponding to 
PRDM14-HA is indicated with an asterisk. (f) NANOG levels were measured using anti-HA or anti-
NANOG antibodies. B-Tubulin was used as a loading control. Western blots were performed once, 
but inducibility of PRDM14-HA and NANOG-HA was also confirmed by strong GFP expression upon 
Dox treatment, since the used piggybac vectors co-express the desired genes together with GFP 
due to an intervening IRES sequence. Source data is provided in the Source Data file. 
g.) ESC lines enabling the inducible overexpression of exogenous NANOG-HA (piggyBac::Nanog) 
or PRMD14-HA (piggyBac::Prdm14) were differentiated into d2 EpiLC and EpiSC. Next, the 
resulting d2 EpiLC or EpiSC were differentiated into PGCLC upon overexpression (+Dox) of 
NANOG-HA or PRDM14-HA and in the absence of growth factors. Similarly, E14 WT d2 EpiLC and 
EpiSC were also differentiated into PGCLC in the presence of growth factors (ctrl + BMP4). 
Representative examples of the PGCLC quantifications performed by FACS after four days of 
PGCLC differentiation are shown. PGCLC were quantified as the percentage of CD15+ CD61+ cells 
found within d4 EB. 
h.) The ESC line enabling the inducible overexpression of exogenous NANOG-HA was 
differentiated into d2 EpiLC and EpiSC. Next, the cells either left untreated (ctrl) or treated with Dox 
for 18 hours and H3K4me2 ChIP-seq experiments were performed. The average profile (top) and 
heatmap (bottom) plots show H3K4me2 levels within Group I and Group II PGCLC enhancers. For 
the comparison between the untreated (ctrl) and Dox-treated cells, a paired Wilcoxon test was 
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Supplementary Fig. 5: Epigenomic and transcriptional characterization of MLL3/4 catalytic 
mutant cells (related to Fig. 5). 
a.) Average profile (top) and heatmap (bottom) plots showing the binding of WT and dCD MLL3/4 
proteins for the Group I and II PGCLC enhancers in 2i ESC (ChIP-seq data from Dorighi et al. 
20179). The WT MLL3/4 ChIP-seq experiments were merged from two replicates. Scales are shown 
in RPGC. 
b.) Summary plot showing the average H3K27ac and H3K4me1 levels in WT and dCT cells (ESC 
and d2 EpiLC) for the EpiLC, EpiSC and PGCLC enhancers as well as the TSS of the PGCLC 
genes. Quantifications were performed by measuring the average signals of each epigenetic mark 
within -/+ 1kb of the enhancers/TSS. RPGC: Reads per genomic content. 
c.) Average profile (top) and heatmap (bottom) plots showing H3K4me2 levels for the Group I and 
Group II PGCLC enhancers in R1 WT and dCD ESC lines as well as upon their differentiation into 
d2 EpiLC and EpiSC. For the comparison between WT and dCD cells, a paired Wilcoxon test was 
performed for each stage and the p-values for Group I and II PGCLC enhancers are indicated. 
Scales are shown in RPGC. 
d.) Summary plot showing the average H3K27ac, H3K4me1, H3K4me2 and H3K4me3 levels in WT 
and dCD cells (d2 EpiLC and EpiSC) for the EpiLC, EpiSC and PGCLC enhancers as well as the 
TSS of the PGCLC genes. Quantifications were performed by measuring the average signals of 
each epigenetic mark within -/+ 1kb of the enhancers or TSS. The H3K4me1 ChIP-seq data shown 
for WT d2 EpiLC and EpiSC are the same ones used in Fig. 3c as a third replicate. RPGC: Reads 
per genomic content. 
e.) The CpG methylation levels of the Esrrb enhancer were determined by bisulfite sequencing in 
R1 WT and dCD d2 EpiLC. The columns of the plots correspond to individual CpG dinucleotides 
located within the Esrrb enhancer. Unmethylated CpGs are shown in blue, methylated CpGs in red 
and CpGs that were not sequenced are shown in gray. The rows represent the sequenced alleles in 
each cell line. 
f.) Summary plot showing the average ratio of methylated CpG in WT and dCD cells (2i ESC and d2 
EpiLC) for the EpiLC, EpiSC and PGCLC enhancers as well as the TSS of the PGCLC genes. 
Quantifications were performed by measuring the average signals of each epigenetic mark within -/
+ 1kb of the enhancers or TSS. 
g.) Genome browser view showing H3K4me1, H3K4me2 and H3K27ac profiles in both WT and 
MLL3/4 catalytic mutant cells (ESC, EpiLC and EpiSC) around representative PGCLC (Prdm14), 
EpiLC (Foxd3) and EpiSC (Foxa2) genes and their associated enhancers.  
h.) Expression levels, as measured by RNA-seq, for the representative PGCLC, EpiLC and EpiSC 
genes shown in Fig. 5c and Supplementary Fig. 5g in WT (gray) and dCD (red) ESC cells as well as 
upon their differentiation into EpiLC and EpiSC. The RNA-seq data in ESC was obtained from 
Dorighi et al. 20179 (n=3) and the experiments in d2 EpiLC and EpiSC were performed in 
duplicates. The barplots show the mean gene expression and the error bars represent the standard 
deviation from all available replicates TPM: transcripts per million. 
i.) Western Blot analysis of the ESRRB and OTX2 protein levels present in WT and dCD ESC as 
well as upon their differentiation into d2 EpiLC. B-Tubulin was used as a loading control. Western 
blots were performed once, but similar results were observed in the RNA-seq data set. Source data 




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Supplementary Fig. 6: Evaluation of the importance of H3K4me1 during PGCLC 
differentiation (related to Fig. 6).
a.) Representative examples of the PGCLC quantifications performed by FACS after four days of 
PGCLC differentiation using WT ESC (R1 WT) or with the indicated MLL3/4 catalytic mutant ESC 
lines. PGCLC were quantified as the CD15+ CD61+ cells found within d4 EB.
b.) WT ESC and Mll3/4 dCD ESC lines were differentiated into PGCLC and PGCLC were 
quantified in d6 instead of d4 EB. Examples are shown on the left and the PGCLC quantification 
of CD15+ CD61+ cells within d6 EB. The bar plots show the mean percentage of PGCLC +/- SD 
from two biological replicates.
c.) Percentage of WT and dCD cells present within each of the clusters identified in d4 EB as 
described in Fig. 6b.
d.) Transcriptional correlation of the main d4 EB clusters as described in (c-d). The violin plot 
shows the spearman correlations of the 1000 most variable genes between single cells of the 
indicated clusters. The horizontal lines in the box plots indicate the median, the boxes the first 
and third quartiles and the whiskers the  ± 1.5 × interquartile range. 
e.) Violin plots showing the transcript levels of all PGCLC genes measured in either WT (red) or 
dCD (blue) cells located within the major cell clusters of the d4 EB clusters in WT (red) and dCD 
(blue). Each dot represents a single cell and the dashed lines show the mean transcript levels of 
the PGCLC genes for all the WT and dCD d4 EB cells except those found within the PGCLC 
cluster.
f.) Heatmap showing the expression of selected PGCLC genes (rows) linked to PGCLC 
enhancers within individual WT and dCD Prdm1orDppa3+/Klf4- cells (columns).
g.) Western blot analysis of the OTX2 levels in Otx2-/- and dCD Otx2-/- d2 EpiLC. B-Tubulin was 
used as a loading control. Western blots were performed once, but the Otx2 deletion was also 
verified by genotyping and qPCR (not shown). Source data provided in the Source Data file.
h.) The CpG methylation levels of the Esrrb enhancer were determined by bisulfite sequencing in 
R1 Otx2-/- and dCD Otx2-/- d2 EpilC. The columns of the plots correspond to individual CpG 
dinucleotides located within the Esrrb enhancer. Unmethylated CpGs are shown in blue, 
methylated CpGs in red and CpGs that were not sequenced are shown in gray. The rows 







































































































































































































































































































































































































e stage ● ● ●E4.5 E5.5 E6.5
Supplementary Fig. 7: Analysis of PGCLC enhancers using in vivo single-cell CpG 
methylation data (related to Fig. 7).
a.) Scatterplots showing the correlation between (left) genome-wide mCpG or (right) CpG 
coverage and the mean mCpG/CpG ratio of all PGCLC enhancers within individual cells 
belonging to E4.5, E5.5 and E6.5 epiblasts (n=261 cells). The correlation coefficient (R) and p-
value were calculated using Spearman correlation.
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